Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-033069
Filing Date
2025-03-05
Accepted
2025-03-05 07:14:14
Documents
5
Effectiveness Date
2025-03-05

Document Format Files

Seq Description Document Type Size
1 S-8 itos_march_5_2025_s-8_ev.htm S-8 95176
2 EX-5.1 itos-ex5_1.htm EX-5.1 12827
3 EX-23.1 itos-ex23_1.htm EX-23.1 3677
4 EX-107 itos-exfiling_fees.htm EX-FILING FEES 24139
5 GRAPHIC img169804041_0.jpg GRAPHIC 29571
  Complete submission text file 0000950170-25-033069.txt   177810
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285550 | Film No.: 25708812
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)